Wet AMD symptoms stem from damage to the macula, the center part of the retina. In most people with AMD, protein deposits called drusen form underneath the retina, which can damage the macula.

Apps may be available on your phone to help you monitor your wet AMD symptoms and assist you with everyday tasks such as reading, texting, and identifying objects. Advanced neovascular age-related ...

There are few signs and symptoms of AMD Due to limited treatment options, catching AMD early is the best way to slow the progression of vision loss. However, AMD is known for having few symptoms ...

Key Takeaways Brolucizumab stabilizes retinal exudation and fluid, improving visual outcomes in wet AMD management. Study showed BCVA and CRT improvements at 6 and 12 months, with minimal adverse ...

Current treatments sometimes fail to help people with "wet" age-related macular degeneration -- and researchers now think they know why. Wet AMD is caused by an overgrowth of blood vessels in the ...

Yes. There are two kinds of macular degeneration — dry and wet, or neovascular. Anywhere from 80% to 90% of the 20 million AMD sufferers in the U.S. have the dry variety.

Wet AMD is a $10 billion market and is expected to grow at a CAGR of 8.2%. The current standard of care for wet AMD involves intravitreal injections of anti-VEGF agents like EYLEA and LUCENTIS.

Session ID: 2025-07-20:3246d1b91fdac472f13480 Player Element ID: Vbe32fac9_74e3_4bf6_9ada_a42fad58a865_6374368325112 ...

Adverum Biotechnologies advances wet AMD treatment with promising trial results. See why ADVM stock has potential as it prepares for the ARTEMIS study in 2025.

Ocular Therapeutix has completed randomization in the first wet AMD trial, SOL-1. The company expects topline results for SOL-1 to be available in the fourth quarter of 2025.